SEATTLE, July 15, 2021 /PRNewswire/ -- An international
team of scientists and data analysts, led by Physician-Scientist
Steven Quay, MD, PhD, has published
a paper entitled, "Science Not Speculation Should Inform the
Investigation of the Origin of COVID-19," in which they conclude:
"Until new evidence is found, an investigation of the pathway for
the origin of COVID-19 should proceed with the assumption that a
laboratory-acquired infection or research-related accident is at
least as likely, if not more likely, than a natural zoonotic
transmission."
The paper was submitted to the Subcommittee on Investigations
and Oversight hearing, Principles for Outbreak Investigation:
COVID-19 and Future Infectious Diseases," held on July 14, 2021.
The preprint, available here, uses the WHO Report and other
reliable data sources to conclude:
- Coronavirus research at laboratories in Wuhan, China was conducted under biosafety
levels (BSL-2 and BLS-3) that are, in general, insufficient for
human pathogens.
- The location of a SARS-like coronavirus outbreak in
Wuhan, the city with the leading
SARS-like coronavirus research institute in the entire world, makes
a laboratory research-related event a leading hypothesis.
- Unlike with previous natural zoonotic epidemics, there was no
evidence of pre-pandemic animal-to-human transmission and no
evidence of an intermediate animal host.
- The virus was genetically pure at the beginning of the outbreak
and the genetic signature of animal-to-human transmission, found in
50% or more of early patients in previous epidemics, is absent with
COVID-19.
"A research-related accident involves a single transmission of a
pure virus to one human and then human-to-human spread," said Dr.
Quay. "In a lab leak there will be no animal hosts found outside of
the lab, no pre-epidemic human infections in stored blood samples
at local hospitals, and the virus will have no background diversity
in its genome. The investigation to date of SARS-CoV-2 and the
COVID-19 pandemic has established these predicted results for a
lab-related event as undisputed facts. Until new evidence is
uncovered, future investigation should proceed with the lab leak as
the leading hypothesis."
About Steven Quay, M.D.,
Ph.D.
Dr. Steven Quay has 360+
published contributions to medicine and has been cited over 10,000
times, placing him in the top 1% of scientists worldwide. He holds
87 US patents and has invented seven FDA-approved pharmaceuticals
which have helped over 80 million people. He is the author of the
best-selling book on surviving the pandemic, Stay Safe: A
Physician's Guide to Survive Coronavirus. He is the CEO of Atossa
Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage
biopharmaceutical company developing novel therapeutics for
oncology and infectious diseases.
He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow
in the Chemistry Department at MIT with
Nobel Laureate H. Gobind Khorana, a
resident at the Harvard-MGH Hospital, and spent almost a decade on
the faculty of Stanford University
School of Medicine. A TEDx talk he delivered on breast cancer
prevention has been viewed over 220,000 times. His scientific
manuscript entitled, "A Bayesian analysis concludes beyond a
reasonable doubt that SARS-CoV-2 is not a natural zoonosis but
instead is laboratory derived," has been viewed over 115,000-time.
For more information, visit www.DrQuay.com
Public Relations Contact:
Dunn Pellier Media| t: 323.481.2307
11620 Wilshire Blvd., 9th Floor, Los Angeles,
CA 90025
Jenn@dunnpelliermedia.com
nicole@dunnpelliermedia.com
View original
content:https://www.prnewswire.com/news-releases/physician-scientist-steven-quay-and-an-international-team-of-scientists-and-investigators-provide-science-based-analysis-of-the-origin-of-covid-19-to-the-us-congress-301334600.html
SOURCE Dr. Steven Quay